Trial intelligence / Profile preview

Use of Metformin to Improve Muscle Regrowth in Older Adults

NCT06185179Phase 1Recruiting

Sponsor
University of Utah
Start
Sep 2024
Primary completion
May 2029
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in muscle atrophy comparing Metformin with Placebo (2 arms). Primary endpoint: Percentage recovery of thigh muscle volume at 14 days. Started Sep 2024; status: recruiting.

02

Drugs

metformin
03

Conditions

muscle atrophy

Beyond the preview

Go deeper on NCT06185179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06185179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call